Zobrazeno 1 - 10
of 51
pro vyhledávání: '"JOO EUN KIM"'
Autor:
Yue Liang, Garvit Bhatt, Lin Tze Tung, HanChen Wang, Joo Eun Kim, Marwah Mousa, Viktoria Plackoska, Katalin Illes, Anna A. Georges, Philippe Gros, Linda Henneman, Ivo J. Huijbers, Bhushan Nagar, Anastasia Nijnik
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Myb-like SWIRM and MPN domains 1 (MYSM1) is a chromatin binding protein with deubiquitinase (DUB) catalytic activity. Rare MYSM1 mutations in human patients result in an inherited bone marrow failure syndrome, highlighting the biomedical sig
Externí odkaz:
https://doaj.org/article/937eeed544fb4764a51b1ba8906b06f2
Autor:
Joo-Eun Kim, Young-Joon Park
Publikováno v:
Cancer Nanotechnology, Vol 13, Iss 1, Pp 1-24 (2022)
Abstract Background Owing to the limited amount of research, there are no nanoparticle-based anticancer agents that use hydrophilic drugs. Therefore, we developed irinotecan-loaded self-agglomerating hyaluronan nanoparticles (ISHNs). While irinotecan
Externí odkaz:
https://doaj.org/article/226a06c989734f02950f669ec4fe2e18
Autor:
Hyeon-A Kim, Joo-Eun Kim
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1219 (2022)
We aimed to develop nafamostat mesylate immediate-release tablets for the treatment of COVID-19 through drug repositioning studies of nafamostat mesylate injection. Nafamostat mesylate is a serine protease inhibitor known to inhibit the activity of t
Externí odkaz:
https://doaj.org/article/a51145f173cc4e228e7b6f63e85f49dd
Publikováno v:
Journal of Pharmaceutical Investigation. 53:407-416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fd8a3dded99b49d1c7f2b09fd3f80bb
https://doi.org/10.1007/s40005-023-00611-4
https://doi.org/10.1007/s40005-023-00611-4
Autor:
Ye-Ji Lee, Joo-Eun Kim
Publikováno v:
Molecules, Vol 27, Iss 9, p 2828 (2022)
Tianeptine tablets are currently marketed to be designed for immediate-release tablets. The tianeptine has a short half-life, making it difficult to design for sustained-release tablets and achieve bioequivalence with the tianeptine immediate-release
Externí odkaz:
https://doaj.org/article/185b02719d094e55849dd1e95bc4fe7f
Publikováno v:
Pharmaceuticals, Vol 15, Iss 4, p 412 (2022)
This study aimed to develop a heat shock protein 90 (Hsp90) inhibitor liquisolid tablet with improved solubility to overcome low bioavailability issues. As an active pharmaceutical ingredient (API), JIN-001, a novel Hsp90 inhibitor, was reported to h
Externí odkaz:
https://doaj.org/article/4c544721c5274ff191cc70fdf13b3f5a
Autor:
Joo-Eun Kim, Young-Joon Park
Publikováno v:
Pharmaceutics, Vol 14, Iss 2, p 377 (2022)
The aim of this study was to develop a single-layered version of commercially available Twynstar® (Telmisartan + Amlodipine) double-layered tablets to improve the dosing convenience. A quality-by-design approach was applied to develop the single-lay
Externí odkaz:
https://doaj.org/article/016c3a37bcf64d358dc36bb2abae34b0
Publikováno v:
Journal of Pharmaceutical Investigation. 52:649-682
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::826dc3fd9fb0f21e7c8abd7dcf902a42
https://doi.org/10.1007/s40005-022-00575-x
https://doi.org/10.1007/s40005-022-00575-x
Autor:
Sang-Ho Lee, Joo-Eun Kim
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 259 (2021)
The aim of this study was to develop immediate-release oral rabeprazole sodium tablets with rapid efficacy and gastric stability for the treatment of gastroesophageal reflux disease. Rabeprazole sodium is a commonly prescribed proton pump inhibitor;
Externí odkaz:
https://doaj.org/article/a290c421e6d24900acc06f8d81455f11
Autor:
Joo-Eun Kim, So-Jin Kang
Publikováno v:
Current Pharmaceutical Analysis. 19
Background: Sitagliptin phosphate monohydrate-dapagliflozin propanediol hydrate fixeddose combination (FDC) dual-layered tablet is used for type 2 diabetes treatment. Simultaneous quantitative analysis can shorten the analysis time of sitagliptin pho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::685e0ba925d275c21bbc31d8615c3285
https://doi.org/10.2174/1573412919666230417081123
https://doi.org/10.2174/1573412919666230417081123